Effects of Risperidone on Cytokine Profile in Drug-Naive First-Episode Psychosis
Article 2014 en
Authors
CN
Cristiano Noto
VO
Vanessa Kiyomi Ota
EG
Eduardo Sauerbronn Gouvêa
Abstract
1 min read
Background:There is robust evidence that schizophrenia is characterized by immune-inflammatory abnormalities, including variations on cytokine levels. The results of previous studies, however, are heterogeneous due to several confounding factors, such as the effects of antipsychotic drugs. Therefore, research on drug-naïve first-episode psychosis (FEP) patients is essential to elucidate the role of immune processes in that disorder.
Daniel Bergé, Anna Mané, Tyler A. Lesh, Miquel Bioque, Fe Barcones, Ana González‐Pinto, Mara Parellada, Eduard Vieta, Josefina Castro‐Fornieles, Roberto Rodríguez–Jiménez, María Paz García‐Portilla, Judith Usall, Cameron S. Carter, Bibiana Cabrera, Miquel Bernardo, Joost Janssen, Gisela Mezquida, Sílvia Amoretti, Laura Pina‐Camacho, Celso Arango, Itxaso González–Ortega, Stéphanie Garcia, Concepción De‐la‐Cámara, N Fayed, Julio Sanjuán, Eduardo J. Aguilar, Joyce Guo, P. Salgado, Joquim Raduà, José Sánchez‐Moreno, Elena de la Serna, Ima Baeza, Fernando Contreras-Fernández,
Christian Núñez, Christian Stephan‐Otto, Judith Usall, Miquel Bioque, António Lobo, Ana González‐Pinto, Laura Pina‐Camacho, Eduard Vieta, Josefina Castro‐Fornieles, Roberto Rodríguez–Jiménez, Anna Butjosa, Joost Janssen, Bibiana Cabrera, Mara Parellada, Miquel Bernardo, Gisela Mezquida, Sílvia Amoretti, Elisa Rodríguez-Toscano, Yasser Alemán‐Gómez, Eric P. Zorrilla, Sainza García, Concepción De‐la‐Cámara, Fe Barcones,
Laura Pina‐Camacho, Kenia Martínez, Covadonga M. Díaz‐Caneja, Gisela Mezquida, Manuel J. Cuesta, Carmen Moreno, Sílvia Amoretti, Ana González‐Pinto, Celso Arango, Eduard Vieta, Josefina Castro‐Fornieles, António Lobo, David Fraguas, Miquel Bernardo, Joost Janssen, Mara Parellada, Santiago Madero, Marta Gómez-Ramiro, Elisa Rodríguez-Toscano, Javier Santonja, Eric P. Zorrilla, Itxaso González–Ortega, Nicolás Fayed, ,
Discussion(0)
No comments yet. Be the first to comment.